Diclofenac associated with cardiovascular health risk
A 20-year population-based study has found the use of diclofenac for pain relief is linked to an increased risk of major adverse cardiovascular events...
Vaccinations: pointing the needle in expanded settings
Pharmacists should be able to administer vaccinations in any health setting.
Appropriately trained and qualified pharmacists across all Australian states and territories can administer...
Q&A: ‘I’m going overseas tomorrow . . . can you witness...
While pharmacists are now (very) familiar with rapid antigen tests (RATs) for COVID-19 testing, the practice of observed RATs for the purpose of international...
Call for pharmacist access to the MBS for Chronic Disease Management
Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense.
After a...
Treating hypertension – a new approach
Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians.
Research has indicated that a new pharmacological...
Ready-to-use tool for oncology
Pharmacists have a new oncology-focused tool for the evaluation and assessment of adverse drug events in oncology.
French researchers have developed a trigger tool to...

Dr Phoebe Holdenson Kimura[/caption]
High-quality medicines reconciliation should ideally occur in the emergency department or soon after admission to the ward.
AP











